Keros Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $57M | 1.4M | 39.76 |
| 2023-09-30 | $45M | 1.4M | 31.88 |
| 2023-06-30 | $48M | 1.2M | 40.18 |
| 2023-03-31 | $45M | 1.0M | 42.70 |
| 2022-12-31 | $50M | 1.0M | 48.02 |
| 2022-06-30 | $21M | 772k | 27.63 |
| 2022-03-31 | $40M | 737k | 54.38 |
| 2021-09-30 | $28M | 710k | 39.56 |
| 2021-06-30 | $28M | 668k | 42.46 |
| 2021-03-31 | $37M | 603k | 61.54 |
| 2020-12-31 | $42M | 592k | 70.53 |
| 2020-09-30 | $12M | 299k | 38.57 |
| 2020-06-30 | $12M | 312k | 37.53 |